Titre:
  • Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.
Auteur:Lehmann-Che, Jacqueline; Andre, Fabrice; Desmedt, Christine; Mazouni, Chafika; Giacchetti, S; Turpin, Elisabeth; Espié, Marc; Plassa, Louis-François; Marty, Michel; Bertheau, Philippe; Sotiriou, Christos; Piccart-Gebhart, Martine; Symmans, W Fraser; Pusztai, Lajos; de Thé, Hugues
Informations sur la publication:The oncologist, 15, 3, page (246-252)
Statut de publication:Publié, 2010
Sujet CREF:Sciences bio-médicales et agricoles
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1083-7159
info:doi/10.1634/theoncologist.2009-0243
info:pii/theoncologist.2009-0243
info:scp/77950530561
info:pmid/20228131